Cardiovascular Health

Should You Start a Statin After 70? The 30% Drop Has a Catch

Starting statins after 70 cut major heart and stroke events from 8 in 100 to 6 in 100 in a six-year trial, but didn't help people live longer.

A grid of white statin tablets on a green background with two coral tablets standing out.

Until recently, whether a healthy person in their 70s should start a statin was mostly guesswork, because the big trials that proved these drugs work were done in younger people. That changed with STAREE, the first large trial built for this age group, which found that statins cut major heart and stroke events, counted together, by about 30% after 70. Statins lower LDL, the cholesterol that builds plaque inside artery walls. In the trial, about 10,000 healthy adults who lived independently took either atorvastatin (Lipitor) or a placebo. So if you’re 72 or 78 and feel fine, does that news mean you should start one?

Quick answer: STAREE looked at statins after 70 in healthy adults who lived independently and didn’t have heart disease, diabetes or dementia. Over six years, 6 in 100 on the statin had a major heart or stroke event, versus about 8 in 100 on placebo. People on the statin didn’t live longer, and they weren’t more likely to stay free of dementia or disability. Whether it pays off depends on your risk and how many years you expect to have.

In this article
  1. What did the trial find, and what didn’t it change?
  2. Do the results apply to you?
  3. What are the trade-offs of starting statins after 70?
  4. Already on a statin: is it safe to stop?
  5. What tips the decision for you and your doctor?

What did the trial find, and what didn’t it change?

The headline 30% is a relative number, and it sounds bigger than it is. In plain terms, about 2 people in every 100 were spared a major heart or stroke event over six years. That’s a real benefit, but it also means most people did fine either way.

It also matters what kind of events the statin prevented. Most of the drop came from heart and stroke events that people survived, while deaths from heart disease were about the same in both groups.

The trial also asked a second question that may matter more at this age: did people stay alive and free of dementia and lasting disability? On that measure, the statin made no real difference, and dementia was neither more nor less common on it. The likely reason is that about 4 in 5 deaths in the trial came from something other than heart or blood vessel disease.

A statin at this stage works a bit like a new roof on a house you love. It holds up well against the next big storm, but it doesn’t touch the plumbing or the wiring.

Over about six yearsStatinPlaceboWhat it means
Major heart or stroke eventsAbout 6 in 100About 8 in 100About 2 in 100 spared
Death, dementia or lasting disabilityAbout 13 in 100About 14 in 100No real difference
Serious side effectsAbout 3 in 100About 3 in 100The same
Muscle complaintsAbout 32 in 100About 29 in 100Common either way
Diabetes-related problems4 in 100About 3 in 100More common on the statin
Liver-related problemsAbout 3 in 100About 1 in 100More common on the statin

Do the results apply to you?

They fit a fairly specific person: someone 70 or older who lives independently, has never had a heart attack, stroke or stent, and doesn’t have diabetes or dementia. The volunteers came from family doctors’ practices in Australia, and people who sign up for trials tend to be healthier than many Americans in their 70s. The benefit looked similar for people in their early 70s and for those 75 and older, so turning 75 didn’t make the drug stop working.

If you’ve already had a heart attack, stroke or stent, this trial isn’t about you. Statins after a first event are a separate question, and it was settled long ago. People with diabetes weren’t included either. Guidelines have their own advice for older adults with diabetes, so that’s a different conversation with a doctor. People who are frail, live with dementia or have limited years ahead weren’t studied, and for them the benefit may arrive too late to matter. If you’re helping a parent who uses a walker and sees several specialists, that last group is the one to look at closely.

What are the trade-offs of starting statins after 70?

Serious side effects were just as common on the placebo as on the statin, which may surprise anyone who has heard statin horror stories from friends. Muscle aches were the big worry going in, and they turned out to be common in both groups. Only about 3 more people in 100 reported them on the statin. A new ache in your shoulder at 74 may be the pill, or it may be the gardening. Either way, mention it to your doctor instead of quietly quitting.

Two kinds of problems did show up more often on the statin: ones tied to blood sugar and ones tied to the liver. The drug label notes that statins can nudge blood sugar up. If you already have prediabetes, your doctor may want to recheck your sugar after you start. As for the liver, the label says to stop the drug and get checked if your skin or eyes turn yellow.

The warning sign the label calls out is muscle pain, tenderness or weakness you can’t explain, especially in the thighs or shoulders. Being over 65 is one of the listed risk factors for muscle injury from statins, along with kidney problems and an underactive thyroid that isn’t under control. If that kind of weakness shows up, call your doctor before your next dose, because the label says you may need to stop the statin while your doctor checks what’s causing it.

Then there’s the simple fact of taking a pill every day. A pill for a problem you can’t feel is a hard habit to keep, and almost half the people on atorvastatin in the trial had stopped taking it within five years.

Already on a statin: is it safe to stop?

A second, smaller trial asked the opposite question. It enrolled people 70 and older who had at least two chronic health conditions and no heart disease. All of them had taken a statin for a year or more, and they were randomly assigned to stop it or keep taking it.

Before the trial began, the researchers set a limit for how much worse stopping could be and still count as acceptable. At about two years, stopping stayed within that limit, but don’t read that as a green light. Over those two years, about 13 in 100 people who stopped had a heart attack or stroke or died. Among those who kept taking the pill, it was about 9 in 100.

The people in this trial were older and sicker than the STAREE volunteers, so the two trials can’t really be compared. For someone who takes a statin without trouble, the evidence doesn’t make a case for stopping just because another birthday passed. Stopping is easier to justify with a specific reason, such as side effects, growing frailty or a shorter life expectancy.

What tips the decision for you and your doctor?

How much time do you expect to have? That’s the first thing to think about. In earlier trials in younger adults, it took about two and a half years before 1 in 100 people treated avoided a heart event. You have to take a statin for a few years before it starts paying off. A healthy 71-year-old has more time to benefit than someone whose other health problems mean fewer years ahead.

Your doctor will usually start by estimating your 10-year heart risk with a standard calculator that works up to age 79. The higher your risk to begin with, the more that 30% cut is worth to you. At 80 and beyond, the calculator doesn’t apply, and the decision comes down to how healthy and independent you are and what you want from the years ahead.

If your risk lands in the middle range, your doctor may suggest a coronary calcium scan, especially if the result would change what you decide. It’s a quick CT that looks for calcium in the heart arteries. Under the 2026 U.S. cholesterol guideline, if your risk is in the middle range and your score is zero, it’s reasonable to hold off and rescan in a few years. That applies to people who don’t smoke and would rather avoid the pill.

What you want most matters just as much. If avoiding a heart attack or a stent is the priority, the trial showed a benefit there. If your bigger worry is staying sharp and independent, the statin didn’t help with that.

U.S. guidance was written before this trial came out. The U.S. Preventive Services Task Force says there isn’t enough evidence to judge whether statins help or harm people 76 and older. The 2026 cholesterol guideline from the American Heart Association and its partner groups asks doctors and patients over 75 to weigh the benefits and risks together.

Before your appointment to talk about statins after 70, write down whether you’ve ever been told you have prediabetes, how your muscles and energy have been lately, and what you most want the next five years to look like. Your doctor will have the risk numbers. Those three answers are your half of the conversation.

More Helpful Reads You Might Like:

Frequently Asked Questions

Is 75 too old to start a statin?

There’s no fixed age cutoff. In the new trial, the benefit looked about the same for people 75 and older as for those in their early 70s. The choice comes down to your own heart risk and your overall health.

Can statins cause memory loss or dementia in older adults?

The trial didn’t find that. Dementia was neither more nor less common among people taking atorvastatin than among those on a placebo over about six years. A U.S. trial in people 75 and older is still studying whether statins affect dementia.

Should an 80-year-old take a statin?

The standard heart risk calculator stops at 79, so at 80 the decision rests on overall health, independence and life expectancy. Because the new trial enrolled healthy, independent volunteers, its results say more about a robust 80-year-old than a frail one.

Is it safe to stop taking a statin after 70?

Not completely. In a trial of people 70 and older with several chronic conditions, those who stopped had more heart attacks, strokes and deaths over two years than those who kept taking it. If the pill isn’t giving you trouble, there’s little reason to stop. Stopping makes more sense with a specific reason, such as side effects or growing frailty.

Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare provider with any questions about a medical condition.

Sources & Further Reading

How we sourced this article: we rely on peer-reviewed studies, clinical guidelines and public-health agencies (CDC, NIH, AHA, WHO), check every link before publishing, and update articles when the evidence changes. Read our editorial approach.

Vital Care Guide Editorial Team

Physician-led editorial team. Every article is written from current guidelines and peer-reviewed sources, cited at the end, and revised when the evidence changes. This content is for information only and is not a substitute for medical advice. How we work

Medically reviewed by Jhonatas Ribeiro, MD, Internal Medicine Specialist

Keep reading